Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Venticute

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
We have read, with great interest, the Letter to the Editor by Grotberg et al.,(1) which puts forward reduced alveolar delivery… Expand
Is this relevant?
2009
2009
Respiratory distress syndrome (RDS) is mainly caused by a deficiency of surfactant in structurally immature lungs. Therapy for… Expand
Is this relevant?
2009
2009
Dr. Taut is an employee of Nycomed, the manufacturer of Venticute; Drs. Rippin and Spragg have contractual and consulting… Expand
Is this relevant?
2008
2008
BACKGROUND Studies to date have shown no survival benefit for the use of exogenous surfactant to treat patients with the ARDS. To… Expand
Is this relevant?
2007
2007
Background: Extensive biochemical and biophysical changes of the pulmonary surfactant system occur in the acute respiratory… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 4
Is this relevant?
2005
2005
Q: Are we doing any harm by giving antibiotics to the mother in preterm labor or to the preterm baby? Dr. Jobe: I do not think so… Expand
Is this relevant?
Review
2004
Review
2004
The inaccurately labelled “natural” surfactants that are currently used to treat infants include: Surfactant TA, Survanta… Expand
Is this relevant?
2001
2001
This paper describes a convenient and practice method for quantitation of surfactant phospholipids (1,2-dipalmitoyl-3-sn… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?